共 50 条
Platelet x CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer
被引:22
作者:
Miyamoto, Ryoichi
[1
]
Oda, Tatsuya
[1
]
Hashimoto, Shinji
[1
]
Kurokawa, Tomohiro
[1
]
Kohno, Keisuke
[1
]
Akashi, Yoshimasa
[1
]
Ohara, Yusuke
[1
]
Yamada, Keiichi
[1
]
Enomoto, Tsuyoshi
[1
]
Ohkohchi, Nobuhiro
[1
]
机构:
[1] Univ Tsukuba, Dept Surg, Div Gastroenterol & Hepatobiliary Surg & Organ Tr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan
来源:
基金:
日本学术振兴会;
关键词:
thrombocytosis;
pancreatic cancer;
platelet;
CRP;
inflammatory response;
prognostic factor;
DUCTAL ADENOCARCINOMA;
VENOUS THROMBOEMBOLISM;
CURATIVE RESECTION;
RECTAL-CANCER;
FREE SURVIVAL;
THROMBOCYTOSIS;
COUNTS;
TRIAL;
RISK;
GEMCITABINE;
D O I:
10.1097/MPA.0000000000000697
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Objective: Thrombocytosis in patients with various cancers has been considered a parameter for poor prognosis; however, its contribution to pancreatic cancer remains controversial. Methods: Potential preoperative prognostic parameters (platelets, neutrophils, lymphocytes, the platelet-lymphocyte ratio, the neutrophil-lymphocyte ratio, the serum C-reactive protein [CRP], and carbohydrate antigen 19-9) were retrospectively analyzed in 95 patients with pancreatic cancer. Cutoff values were defined according to receiver operating characteristic curve analysis, and median survival times (MSTs) were compared. Results: Median survival times (days) significantly differed according to platelet count (high [552] vs low [735], P = 0.017), CRP (high [471] vs low [750], P = 0.001), and carbohydrate antigen 19-9 level (high [639] vs low [765], P = 0.021), whereas there was no difference in the platelet-lymphocyte ratio and the neutrophil-lymphocyte ratio. Multivariate analysis identified thrombocytosis (hazard ratio, 2.015) and CRP level (hazard ratio, 1.771) as independent prognostic factors. The combinatory effects of platelets and the inflammatory response using a platelet x CRP multiplier value could effectively distinguished the MSTs (days) of patients with pancreatic cancer (high [482] vs low [812], P < 0.001). Conclusions: Thrombocytosis and CRP influenced pancreatic cancer patient prognosis. Platelet x CRP multiplier is assumed as a useful parameter that reflects the contribution of activated platelets to cancer progression.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 50 条